Majority of Life Sciences Leaders Implement AI Governance Frameworks
A new industry report finds that 64 percent of life sciences executives are establishing AI governance. Lack of trust and standardized protocols remain the primary hurdles to scaling autonomous AI agents.
Life sciences industry leaders are increasingly focusing on the regulation of artificial intelligence, with 64 percent taking steps to implement formal governance structures. The shift comes as organizations navigate the complexities of integrating advanced computing into highly regulated environments.
While organizations are prioritizing AI deployment, the survey indicates that trust serves as a significant barrier to scaling the use of AI agents. Approximately 58 percent of industry participants cited the absence of sector-wide standards as a major impediment to progress, highlighting a disconnect between technological potential and operational readiness.
The findings underscore a sector-wide realization that technological advancement cannot outpace regulatory oversight. To move forward, industry players are expected to focus on building internal frameworks that address security, ethical considerations, and data integrity to bridge the current trust gap.